Literature DB >> 11575344

Double-blind comparison of ropivacaine 7.5 mg ml(-1) with bupivacaine 5 mg ml(-1) for sciatic nerve block.

C Connolly1, D M Coventry, J A Wildsmith.   

Abstract

Two groups of 12 patients had a sciatic nerve block performed with 20 ml of either ropivacaine 7.5 mg ml(-1) or bupivacaine 5 mg ml(-1). There was no statistically significant difference in the mean time to onset of complete anaesthesia of the foot or to first request for post-operative analgesia. The quality of the block was the same in each group. Although there was no statistically significant difference in the mean time to peak plasma concentrations the mean peak concentration of ropivacaine was significantly higher than that of bupivacaine. There were no signs of systemic local anaesthetic toxicity in any patient in either group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575344     DOI: 10.1093/bja/86.5.674

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers.

Authors:  David Rice; Justin W Heil; Lukasz Biernat
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

2.  Similar analgesic effect after popliteal fossa nerve blockade with 0.375% and 0.75% bupivacaine.

Authors:  Jacques T Ya Deau; Barbara U Wukovits; Vincent R LaSala; Kethy M Jules-Elysée; Leonardo Paroli; Richard L Kahn; David S Levine; Jane Y Lipnitsky
Journal:  HSS J       Date:  2007-09

3.  Ropivacaine versus levobupivacaine in peripheral nerve block: A PRISMA-compliant meta-analysis of randomized controlled trials.

Authors:  Ang Li; Zhijian Wei; Yang Liu; Jiaxiao Shi; Han Ding; Haoshuai Tang; Pengyuan Zheng; Yanzheng Gao; Shiqing Feng
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.